StonvexLoading…
StonvexStonvexStonvexCore line items from MDRR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $10.40M | $9.74M | $10.27M | $11.09M |
Operating Income | $547.90K | $3.73M | $-997.16K | $-1.41M |
Net Income | $-2.39M | $27.52K | $-4.57M | $-4.77M |
EPS (Diluted) | $-1.90 | $0.03 | $-4.12 | $-2.23 |
Total Assets | $77.74M | $75.10M | $82.75M | $87.92M |
Total Liabilities | $53.63M | $54.10M | $69.02M | $69.22M |
Cash & Equivalents | $2.63M | $4.78M | $2.23M | $3.92M |
Free Cash Flow OCF − CapEx | $76.99K | $893.74K | $-1.38M | $175.32K |
Shares Outstanding | 1.11M | 1.35M | 1.11M | 2.22M |